Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- cangrelor
- Persantine (dipyridamole)
Interactions between your drugs
dipyridamole cangrelor
Applies to: Persantine (dipyridamole), cangrelor
Using cangrelor together with dipyridamole may increase the risk of bleeding, including severe and life-threatening hemorrhage. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience any unusual bleeding or bruising, or have other signs and symptoms of bleeding such as dizziness; lightheadedness; red or black, tarry stools; coughing up or vomiting fresh or dried blood that looks like coffee grounds; severe headache; and weakness. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
dipyridamole food/lifestyle
Applies to: Persantine (dipyridamole)
Caffeine may interfere with the effects of dipyridamole in dilating the arteries. You should avoid caffeine-containing products for at least 24 hours before an imaging procedure involving dipyridamole given by injection. However, no special precaution is necessary if you are taking dipyridamole orally for maintenance.
dipyridamole food/lifestyle
Applies to: Persantine (dipyridamole)
Ask your doctor before using dipyridamole together with caffeine. Using these medications together can decrease the effects of dipyridamole. It is recommended that caffeine including caffeine be avoided for 12 to 24 hours before dipyridamole administration. You may need a dose adjustment or special test if you use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Plavix
Plavix (clopidogrel) is used to prevent blood clots after a recent heart attack or stroke. Includes ...
Integrilin
Integrilin prevents blood clots or heart attack in people with severe chest pain and in patients ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Angiomax
Angiomax is used for angina, percutaneous coronary intervention
ReoPro
ReoPro is used to lessen the chance of heart attack in people who need percutaneous coronary ...
Abciximab
Abciximab is used for high risk percutaneous transluminal angioplasty
Eptifibatide
Eptifibatide is used for acute coronary syndrome, angina, heart attack, percutaneous coronary ...
Bivalirudin
Bivalirudin is used for angina, percutaneous coronary intervention
Clopidogrel
Clopidogrel is used for acute coronary syndrome, acute coronary syndrome, prophylaxis, heart ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.